nodes	percent_of_prediction	percent_of_DWPC	metapath
Terazosin—ADRA1D—Amitriptyline—migraine	0.161	0.258	CbGbCtD
Terazosin—ADRA1B—Amitriptyline—migraine	0.117	0.188	CbGbCtD
Terazosin—KCNH2—Verapamil—migraine	0.108	0.174	CbGbCtD
Terazosin—ADRA1A—Amitriptyline—migraine	0.0924	0.148	CbGbCtD
Terazosin—ABCB1—Timolol—migraine	0.0442	0.0708	CbGbCtD
Terazosin—ABCB1—Propranolol—migraine	0.0394	0.0631	CbGbCtD
Terazosin—ABCB1—Amitriptyline—migraine	0.034	0.0546	CbGbCtD
Terazosin—ABCB1—Verapamil—migraine	0.027	0.0433	CbGbCtD
Terazosin—Prazosin—HTR1D—migraine	0.00416	0.68	CrCbGaD
Terazosin—Prazosin—HTR1A—migraine	0.00195	0.319	CrCbGaD
Terazosin—KCNH7—head—migraine	0.00157	0.069	CbGeAlD
Terazosin—KCNH7—nervous system—migraine	0.00149	0.0654	CbGeAlD
Terazosin—KCNH7—central nervous system—migraine	0.00143	0.063	CbGeAlD
Terazosin—KCNH7—cerebellum—migraine	0.0014	0.0616	CbGeAlD
Terazosin—KCNH7—brain—migraine	0.00114	0.05	CbGeAlD
Terazosin—KCNH6—head—migraine	0.00112	0.0492	CbGeAlD
Terazosin—KCNH6—nervous system—migraine	0.00106	0.0466	CbGeAlD
Terazosin—KCNH6—central nervous system—migraine	0.00102	0.0449	CbGeAlD
Terazosin—KCNH6—brain—migraine	0.000811	0.0356	CbGeAlD
Terazosin—KCNH2—trigeminal ganglion—migraine	0.000703	0.0309	CbGeAlD
Terazosin—ADRA1A—brainstem—migraine	0.000645	0.0283	CbGeAlD
Terazosin—ADRA1B—head—migraine	0.000634	0.0278	CbGeAlD
Terazosin—ADRA1D—head—migraine	0.00062	0.0272	CbGeAlD
Terazosin—ADRA1B—nervous system—migraine	0.000601	0.0264	CbGeAlD
Terazosin—ADRA1D—nervous system—migraine	0.000588	0.0258	CbGeAlD
Terazosin—ADRA1B—central nervous system—migraine	0.000579	0.0254	CbGeAlD
Terazosin—ADRA1D—central nervous system—migraine	0.000566	0.0249	CbGeAlD
Terazosin—ADRA1A—cardiovascular system—migraine	0.000526	0.0231	CbGeAlD
Terazosin—KCNH2—cardiovascular system—migraine	0.000508	0.0223	CbGeAlD
Terazosin—ABCB1—blood vessel—migraine	0.0005	0.0219	CbGeAlD
Terazosin—ADRA1B—brain—migraine	0.000459	0.0202	CbGeAlD
Terazosin—ADRA1D—brain—migraine	0.000449	0.0197	CbGeAlD
Terazosin—Headache—Amitriptyline—migraine	0.00038	0.00163	CcSEcCtD
Terazosin—Bronchitis—Topiramate—migraine	0.00038	0.00163	CcSEcCtD
Terazosin—Eye disorder—Timolol—migraine	0.000377	0.00162	CcSEcCtD
Terazosin—Rhinitis—Gabapentin—migraine	0.000377	0.00162	CcSEcCtD
Terazosin—Tinnitus—Timolol—migraine	0.000376	0.00162	CcSEcCtD
Terazosin—Feeling abnormal—Verapamil—migraine	0.000375	0.00161	CcSEcCtD
Terazosin—Pharyngitis—Gabapentin—migraine	0.000373	0.0016	CcSEcCtD
Terazosin—Vision blurred—Valproic Acid—migraine	0.000372	0.0016	CcSEcCtD
Terazosin—Oedema peripheral—Gabapentin—migraine	0.00037	0.00159	CcSEcCtD
Terazosin—Tremor—Valproic Acid—migraine	0.00037	0.00159	CcSEcCtD
Terazosin—Dysuria—Topiramate—migraine	0.00037	0.00159	CcSEcCtD
Terazosin—Ill-defined disorder—Valproic Acid—migraine	0.000366	0.00157	CcSEcCtD
Terazosin—Pollakiuria—Topiramate—migraine	0.000365	0.00157	CcSEcCtD
Terazosin—Hypersensitivity—Propranolol—migraine	0.000364	0.00156	CcSEcCtD
Terazosin—Erectile dysfunction—Topiramate—migraine	0.000364	0.00156	CcSEcCtD
Terazosin—Visual impairment—Gabapentin—migraine	0.000362	0.00156	CcSEcCtD
Terazosin—Angioedema—Valproic Acid—migraine	0.000361	0.00155	CcSEcCtD
Terazosin—Photosensitivity reaction—Topiramate—migraine	0.000361	0.00155	CcSEcCtD
Terazosin—Arrhythmia—Timolol—migraine	0.000361	0.00155	CcSEcCtD
Terazosin—Nausea—Amitriptyline—migraine	0.00036	0.00155	CcSEcCtD
Terazosin—Weight increased—Topiramate—migraine	0.00036	0.00154	CcSEcCtD
Terazosin—ADRA1A—head—migraine	0.000356	0.0156	CbGeAlD
Terazosin—Malaise—Valproic Acid—migraine	0.000356	0.00153	CcSEcCtD
Terazosin—Vertigo—Valproic Acid—migraine	0.000355	0.00152	CcSEcCtD
Terazosin—Asthenia—Propranolol—migraine	0.000355	0.00152	CcSEcCtD
Terazosin—Malnutrition—Timolol—migraine	0.000352	0.00151	CcSEcCtD
Terazosin—Eye disorder—Gabapentin—migraine	0.000351	0.00151	CcSEcCtD
Terazosin—Depression—Topiramate—migraine	0.000351	0.00151	CcSEcCtD
Terazosin—Tinnitus—Gabapentin—migraine	0.000351	0.00151	CcSEcCtD
Terazosin—Palpitations—Valproic Acid—migraine	0.000349	0.0015	CcSEcCtD
Terazosin—Tension—Timolol—migraine	0.000345	0.00148	CcSEcCtD
Terazosin—Cough—Valproic Acid—migraine	0.000345	0.00148	CcSEcCtD
Terazosin—Dysgeusia—Timolol—migraine	0.000344	0.00148	CcSEcCtD
Terazosin—KCNH2—head—migraine	0.000344	0.0151	CbGeAlD
Terazosin—Urinary tract infection—Topiramate—migraine	0.000343	0.00147	CcSEcCtD
Terazosin—Conjunctivitis—Topiramate—migraine	0.000343	0.00147	CcSEcCtD
Terazosin—Nervousness—Timolol—migraine	0.000341	0.00147	CcSEcCtD
Terazosin—Diarrhoea—Propranolol—migraine	0.000338	0.00145	CcSEcCtD
Terazosin—ADRA1A—nervous system—migraine	0.000338	0.0148	CbGeAlD
Terazosin—Chest pain—Valproic Acid—migraine	0.000336	0.00144	CcSEcCtD
Terazosin—Myalgia—Valproic Acid—migraine	0.000336	0.00144	CcSEcCtD
Terazosin—Arthralgia—Valproic Acid—migraine	0.000336	0.00144	CcSEcCtD
Terazosin—Anxiety—Valproic Acid—migraine	0.000335	0.00144	CcSEcCtD
Terazosin—Hypersensitivity—Verapamil—migraine	0.000335	0.00144	CcSEcCtD
Terazosin—Epistaxis—Topiramate—migraine	0.000332	0.00143	CcSEcCtD
Terazosin—Discomfort—Valproic Acid—migraine	0.000332	0.00143	CcSEcCtD
Terazosin—Vision blurred—Timolol—migraine	0.000331	0.00142	CcSEcCtD
Terazosin—Sinusitis—Topiramate—migraine	0.000331	0.00142	CcSEcCtD
Terazosin—Dry mouth—Valproic Acid—migraine	0.000329	0.00141	CcSEcCtD
Terazosin—Malnutrition—Gabapentin—migraine	0.000327	0.00141	CcSEcCtD
Terazosin—Dizziness—Propranolol—migraine	0.000327	0.0014	CcSEcCtD
Terazosin—KCNH2—nervous system—migraine	0.000326	0.0143	CbGeAlD
Terazosin—Asthenia—Verapamil—migraine	0.000326	0.0014	CcSEcCtD
Terazosin—ADRA1A—central nervous system—migraine	0.000325	0.0143	CbGeAlD
Terazosin—Confusional state—Valproic Acid—migraine	0.000325	0.0014	CcSEcCtD
Terazosin—Flatulence—Gabapentin—migraine	0.000323	0.00139	CcSEcCtD
Terazosin—Oedema—Valproic Acid—migraine	0.000322	0.00138	CcSEcCtD
Terazosin—Anaphylactic shock—Valproic Acid—migraine	0.000322	0.00138	CcSEcCtD
Terazosin—Pruritus—Verapamil—migraine	0.000322	0.00138	CcSEcCtD
Terazosin—Tension—Gabapentin—migraine	0.000321	0.00138	CcSEcCtD
Terazosin—Angioedema—Timolol—migraine	0.000321	0.00138	CcSEcCtD
Terazosin—Dysgeusia—Gabapentin—migraine	0.000321	0.00138	CcSEcCtD
Terazosin—Nervousness—Gabapentin—migraine	0.000318	0.00137	CcSEcCtD
Terazosin—ADRA1A—cerebellum—migraine	0.000318	0.014	CbGeAlD
Terazosin—Rhinitis—Topiramate—migraine	0.000317	0.00136	CcSEcCtD
Terazosin—Back pain—Gabapentin—migraine	0.000317	0.00136	CcSEcCtD
Terazosin—Vertigo—Timolol—migraine	0.000316	0.00136	CcSEcCtD
Terazosin—Thrombocytopenia—Valproic Acid—migraine	0.000316	0.00136	CcSEcCtD
Terazosin—Syncope—Timolol—migraine	0.000315	0.00135	CcSEcCtD
Terazosin—Tachycardia—Valproic Acid—migraine	0.000315	0.00135	CcSEcCtD
Terazosin—Vomiting—Propranolol—migraine	0.000314	0.00135	CcSEcCtD
Terazosin—KCNH2—central nervous system—migraine	0.000314	0.0138	CbGeAlD
Terazosin—Pharyngitis—Topiramate—migraine	0.000314	0.00135	CcSEcCtD
Terazosin—Oedema peripheral—Topiramate—migraine	0.000312	0.00134	CcSEcCtD
Terazosin—Hyperhidrosis—Valproic Acid—migraine	0.000312	0.00134	CcSEcCtD
Terazosin—Rash—Propranolol—migraine	0.000312	0.00134	CcSEcCtD
Terazosin—Dermatitis—Propranolol—migraine	0.000311	0.00134	CcSEcCtD
Terazosin—Diarrhoea—Verapamil—migraine	0.000311	0.00134	CcSEcCtD
Terazosin—Palpitations—Timolol—migraine	0.000311	0.00133	CcSEcCtD
Terazosin—Loss of consciousness—Timolol—migraine	0.000309	0.00133	CcSEcCtD
Terazosin—ABCB1—trigeminal ganglion—migraine	0.000309	0.0136	CbGeAlD
Terazosin—Vision blurred—Gabapentin—migraine	0.000308	0.00132	CcSEcCtD
Terazosin—Anorexia—Valproic Acid—migraine	0.000307	0.00132	CcSEcCtD
Terazosin—KCNH2—cerebellum—migraine	0.000307	0.0135	CbGeAlD
Terazosin—Cough—Timolol—migraine	0.000307	0.00132	CcSEcCtD
Terazosin—Tremor—Gabapentin—migraine	0.000307	0.00132	CcSEcCtD
Terazosin—Visual impairment—Topiramate—migraine	0.000305	0.00131	CcSEcCtD
Terazosin—Ill-defined disorder—Gabapentin—migraine	0.000304	0.0013	CcSEcCtD
Terazosin—Hypotension—Valproic Acid—migraine	0.000301	0.00129	CcSEcCtD
Terazosin—Dizziness—Verapamil—migraine	0.000301	0.00129	CcSEcCtD
Terazosin—Chest pain—Timolol—migraine	0.000299	0.00129	CcSEcCtD
Terazosin—Arthralgia—Timolol—migraine	0.000299	0.00129	CcSEcCtD
Terazosin—Myalgia—Timolol—migraine	0.000299	0.00129	CcSEcCtD
Terazosin—Angioedema—Gabapentin—migraine	0.000299	0.00128	CcSEcCtD
Terazosin—Anxiety—Timolol—migraine	0.000298	0.00128	CcSEcCtD
Terazosin—Discomfort—Timolol—migraine	0.000296	0.00127	CcSEcCtD
Terazosin—Eye disorder—Topiramate—migraine	0.000296	0.00127	CcSEcCtD
Terazosin—Malaise—Gabapentin—migraine	0.000295	0.00127	CcSEcCtD
Terazosin—Tinnitus—Topiramate—migraine	0.000295	0.00127	CcSEcCtD
Terazosin—Vertigo—Gabapentin—migraine	0.000294	0.00126	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Valproic Acid—migraine	0.000294	0.00126	CcSEcCtD
Terazosin—Syncope—Gabapentin—migraine	0.000294	0.00126	CcSEcCtD
Terazosin—Nausea—Propranolol—migraine	0.000293	0.00126	CcSEcCtD
Terazosin—Dry mouth—Timolol—migraine	0.000293	0.00126	CcSEcCtD
Terazosin—Insomnia—Valproic Acid—migraine	0.000291	0.00125	CcSEcCtD
Terazosin—Paraesthesia—Valproic Acid—migraine	0.000289	0.00124	CcSEcCtD
Terazosin—Palpitations—Gabapentin—migraine	0.000289	0.00124	CcSEcCtD
Terazosin—Confusional state—Timolol—migraine	0.000289	0.00124	CcSEcCtD
Terazosin—Vomiting—Verapamil—migraine	0.000289	0.00124	CcSEcCtD
Terazosin—Loss of consciousness—Gabapentin—migraine	0.000288	0.00124	CcSEcCtD
Terazosin—Dyspnoea—Valproic Acid—migraine	0.000287	0.00123	CcSEcCtD
Terazosin—Anaphylactic shock—Timolol—migraine	0.000287	0.00123	CcSEcCtD
Terazosin—Oedema—Timolol—migraine	0.000287	0.00123	CcSEcCtD
Terazosin—Rash—Verapamil—migraine	0.000287	0.00123	CcSEcCtD
Terazosin—Somnolence—Valproic Acid—migraine	0.000286	0.00123	CcSEcCtD
Terazosin—Dermatitis—Verapamil—migraine	0.000286	0.00123	CcSEcCtD
Terazosin—Cough—Gabapentin—migraine	0.000286	0.00123	CcSEcCtD
Terazosin—Headache—Verapamil—migraine	0.000285	0.00122	CcSEcCtD
Terazosin—Dyspepsia—Valproic Acid—migraine	0.000284	0.00122	CcSEcCtD
Terazosin—Convulsion—Gabapentin—migraine	0.000284	0.00122	CcSEcCtD
Terazosin—Shock—Timolol—migraine	0.000282	0.00121	CcSEcCtD
Terazosin—Decreased appetite—Valproic Acid—migraine	0.00028	0.0012	CcSEcCtD
Terazosin—Myalgia—Gabapentin—migraine	0.000279	0.0012	CcSEcCtD
Terazosin—Chest pain—Gabapentin—migraine	0.000279	0.0012	CcSEcCtD
Terazosin—Arthralgia—Gabapentin—migraine	0.000279	0.0012	CcSEcCtD
Terazosin—Fatigue—Valproic Acid—migraine	0.000278	0.00119	CcSEcCtD
Terazosin—Anxiety—Gabapentin—migraine	0.000278	0.00119	CcSEcCtD
Terazosin—Hyperhidrosis—Timolol—migraine	0.000277	0.00119	CcSEcCtD
Terazosin—Constipation—Valproic Acid—migraine	0.000276	0.00118	CcSEcCtD
Terazosin—Pain—Valproic Acid—migraine	0.000276	0.00118	CcSEcCtD
Terazosin—Malnutrition—Topiramate—migraine	0.000275	0.00118	CcSEcCtD
Terazosin—Discomfort—Gabapentin—migraine	0.000275	0.00118	CcSEcCtD
Terazosin—Anorexia—Timolol—migraine	0.000273	0.00117	CcSEcCtD
Terazosin—Dry mouth—Gabapentin—migraine	0.000273	0.00117	CcSEcCtD
Terazosin—Flatulence—Topiramate—migraine	0.000271	0.00117	CcSEcCtD
Terazosin—Tension—Topiramate—migraine	0.00027	0.00116	CcSEcCtD
Terazosin—Nausea—Verapamil—migraine	0.00027	0.00116	CcSEcCtD
Terazosin—Dysgeusia—Topiramate—migraine	0.00027	0.00116	CcSEcCtD
Terazosin—Confusional state—Gabapentin—migraine	0.000269	0.00116	CcSEcCtD
Terazosin—Hypotension—Timolol—migraine	0.000268	0.00115	CcSEcCtD
Terazosin—Nervousness—Topiramate—migraine	0.000267	0.00115	CcSEcCtD
Terazosin—Anaphylactic shock—Gabapentin—migraine	0.000267	0.00115	CcSEcCtD
Terazosin—Oedema—Gabapentin—migraine	0.000267	0.00115	CcSEcCtD
Terazosin—Back pain—Topiramate—migraine	0.000266	0.00114	CcSEcCtD
Terazosin—Feeling abnormal—Valproic Acid—migraine	0.000266	0.00114	CcSEcCtD
Terazosin—Gastrointestinal pain—Valproic Acid—migraine	0.000264	0.00113	CcSEcCtD
Terazosin—Shock—Gabapentin—migraine	0.000263	0.00113	CcSEcCtD
Terazosin—Thrombocytopenia—Gabapentin—migraine	0.000262	0.00112	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Timolol—migraine	0.000261	0.00112	CcSEcCtD
Terazosin—Tachycardia—Gabapentin—migraine	0.000261	0.00112	CcSEcCtD
Terazosin—Vision blurred—Topiramate—migraine	0.00026	0.00111	CcSEcCtD
Terazosin—Insomnia—Timolol—migraine	0.000259	0.00111	CcSEcCtD
Terazosin—Hyperhidrosis—Gabapentin—migraine	0.000258	0.00111	CcSEcCtD
Terazosin—ADRA1A—brain—migraine	0.000258	0.0113	CbGeAlD
Terazosin—Tremor—Topiramate—migraine	0.000258	0.00111	CcSEcCtD
Terazosin—Paraesthesia—Timolol—migraine	0.000258	0.00111	CcSEcCtD
Terazosin—Dyspnoea—Timolol—migraine	0.000256	0.0011	CcSEcCtD
Terazosin—Ill-defined disorder—Topiramate—migraine	0.000256	0.0011	CcSEcCtD
Terazosin—Somnolence—Timolol—migraine	0.000255	0.0011	CcSEcCtD
Terazosin—Abdominal pain—Valproic Acid—migraine	0.000255	0.00109	CcSEcCtD
Terazosin—Body temperature increased—Valproic Acid—migraine	0.000255	0.00109	CcSEcCtD
Terazosin—Anorexia—Gabapentin—migraine	0.000255	0.00109	CcSEcCtD
Terazosin—Dyspepsia—Timolol—migraine	0.000253	0.00108	CcSEcCtD
Terazosin—Hypotension—Gabapentin—migraine	0.00025	0.00107	CcSEcCtD
Terazosin—Decreased appetite—Timolol—migraine	0.000249	0.00107	CcSEcCtD
Terazosin—KCNH2—brain—migraine	0.000249	0.011	CbGeAlD
Terazosin—Malaise—Topiramate—migraine	0.000248	0.00107	CcSEcCtD
Terazosin—ADRA1A—GPCR ligand binding—CALCRL—migraine	0.000248	0.00216	CbGpPWpGaD
Terazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000247	0.00215	CbGpPWpGaD
Terazosin—Vertigo—Topiramate—migraine	0.000247	0.00106	CcSEcCtD
Terazosin—Fatigue—Timolol—migraine	0.000247	0.00106	CcSEcCtD
Terazosin—Syncope—Topiramate—migraine	0.000247	0.00106	CcSEcCtD
Terazosin—Pain—Timolol—migraine	0.000245	0.00105	CcSEcCtD
Terazosin—ADRA1D—GPCR ligand binding—HTR1D—migraine	0.000244	0.00212	CbGpPWpGaD
Terazosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—migraine	0.000244	0.00212	CbGpPWpGaD
Terazosin—Musculoskeletal discomfort—Gabapentin—migraine	0.000243	0.00105	CcSEcCtD
Terazosin—Palpitations—Topiramate—migraine	0.000243	0.00105	CcSEcCtD
Terazosin—Loss of consciousness—Topiramate—migraine	0.000242	0.00104	CcSEcCtD
Terazosin—Insomnia—Gabapentin—migraine	0.000242	0.00104	CcSEcCtD
Terazosin—Cough—Topiramate—migraine	0.00024	0.00103	CcSEcCtD
Terazosin—Paraesthesia—Gabapentin—migraine	0.00024	0.00103	CcSEcCtD
Terazosin—Convulsion—Topiramate—migraine	0.000239	0.00102	CcSEcCtD
Terazosin—Dyspnoea—Gabapentin—migraine	0.000238	0.00102	CcSEcCtD
Terazosin—Somnolence—Gabapentin—migraine	0.000238	0.00102	CcSEcCtD
Terazosin—Hypersensitivity—Valproic Acid—migraine	0.000237	0.00102	CcSEcCtD
Terazosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—migraine	0.000237	0.00206	CbGpPWpGaD
Terazosin—Feeling abnormal—Timolol—migraine	0.000236	0.00102	CcSEcCtD
Terazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.000236	0.00206	CbGpPWpGaD
Terazosin—Dyspepsia—Gabapentin—migraine	0.000235	0.00101	CcSEcCtD
Terazosin—Gastrointestinal pain—Timolol—migraine	0.000235	0.00101	CcSEcCtD
Terazosin—Myalgia—Topiramate—migraine	0.000234	0.00101	CcSEcCtD
Terazosin—Arthralgia—Topiramate—migraine	0.000234	0.00101	CcSEcCtD
Terazosin—Chest pain—Topiramate—migraine	0.000234	0.00101	CcSEcCtD
Terazosin—Anxiety—Topiramate—migraine	0.000234	0.001	CcSEcCtD
Terazosin—Decreased appetite—Gabapentin—migraine	0.000232	0.000997	CcSEcCtD
Terazosin—Discomfort—Topiramate—migraine	0.000232	0.000995	CcSEcCtD
Terazosin—Asthenia—Valproic Acid—migraine	0.000231	0.000993	CcSEcCtD
Terazosin—ADRA1B—G alpha (q) signalling events—NPS—migraine	0.000231	0.00201	CbGpPWpGaD
Terazosin—ADRA1B—G alpha (q) signalling events—TAC1—migraine	0.000231	0.00201	CbGpPWpGaD
Terazosin—Fatigue—Gabapentin—migraine	0.00023	0.000989	CcSEcCtD
Terazosin—Dry mouth—Topiramate—migraine	0.000229	0.000985	CcSEcCtD
Terazosin—Pain—Gabapentin—migraine	0.000228	0.000981	CcSEcCtD
Terazosin—Constipation—Gabapentin—migraine	0.000228	0.000981	CcSEcCtD
Terazosin—Pruritus—Valproic Acid—migraine	0.000228	0.000979	CcSEcCtD
Terazosin—ADRA1D—GPCR ligand binding—HTR2B—migraine	0.000227	0.00198	CbGpPWpGaD
Terazosin—Body temperature increased—Timolol—migraine	0.000227	0.000974	CcSEcCtD
Terazosin—Abdominal pain—Timolol—migraine	0.000227	0.000974	CcSEcCtD
Terazosin—ADRA1D—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.000227	0.00197	CbGpPWpGaD
Terazosin—Confusional state—Topiramate—migraine	0.000227	0.000973	CcSEcCtD
Terazosin—ADRA1B—G alpha (q) signalling events—HTR2C—migraine	0.000226	0.00197	CbGpPWpGaD
Terazosin—Oedema—Topiramate—migraine	0.000225	0.000965	CcSEcCtD
Terazosin—ABCB1—cardiovascular system—migraine	0.000223	0.00979	CbGeAlD
Terazosin—Shock—Topiramate—migraine	0.000221	0.00095	CcSEcCtD
Terazosin—Diarrhoea—Valproic Acid—migraine	0.00022	0.000947	CcSEcCtD
Terazosin—ADRA1B—G alpha (q) signalling events—EDNRA—migraine	0.00022	0.00192	CbGpPWpGaD
Terazosin—Feeling abnormal—Gabapentin—migraine	0.00022	0.000945	CcSEcCtD
Terazosin—Thrombocytopenia—Topiramate—migraine	0.00022	0.000945	CcSEcCtD
Terazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.00022	0.00191	CbGpPWpGaD
Terazosin—Tachycardia—Topiramate—migraine	0.000219	0.000942	CcSEcCtD
Terazosin—Gastrointestinal pain—Gabapentin—migraine	0.000218	0.000938	CcSEcCtD
Terazosin—ADRA1D—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.000218	0.0019	CbGpPWpGaD
Terazosin—Hyperhidrosis—Topiramate—migraine	0.000217	0.000933	CcSEcCtD
Terazosin—Anorexia—Topiramate—migraine	0.000214	0.00092	CcSEcCtD
Terazosin—Dizziness—Valproic Acid—migraine	0.000213	0.000915	CcSEcCtD
Terazosin—Hypersensitivity—Timolol—migraine	0.000211	0.000908	CcSEcCtD
Terazosin—Body temperature increased—Gabapentin—migraine	0.000211	0.000907	CcSEcCtD
Terazosin—Abdominal pain—Gabapentin—migraine	0.000211	0.000907	CcSEcCtD
Terazosin—ADRA1D—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.000211	0.00183	CbGpPWpGaD
Terazosin—Hypotension—Topiramate—migraine	0.00021	0.000902	CcSEcCtD
Terazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—migraine	0.000206	0.0018	CbGpPWpGaD
Terazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—migraine	0.000206	0.0018	CbGpPWpGaD
Terazosin—Asthenia—Timolol—migraine	0.000206	0.000884	CcSEcCtD
Terazosin—ADRA1D—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.000205	0.00178	CbGpPWpGaD
Terazosin—ADRA1A—G alpha (q) signalling events—NPS—migraine	0.000205	0.00178	CbGpPWpGaD
Terazosin—ADRA1A—G alpha (q) signalling events—TAC1—migraine	0.000205	0.00178	CbGpPWpGaD
Terazosin—Vomiting—Valproic Acid—migraine	0.000205	0.00088	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Topiramate—migraine	0.000205	0.000879	CcSEcCtD
Terazosin—Insomnia—Topiramate—migraine	0.000203	0.000873	CcSEcCtD
Terazosin—Rash—Valproic Acid—migraine	0.000203	0.000873	CcSEcCtD
Terazosin—Dermatitis—Valproic Acid—migraine	0.000203	0.000872	CcSEcCtD
Terazosin—Pruritus—Timolol—migraine	0.000203	0.000872	CcSEcCtD
Terazosin—ADRA1B—GPCR ligand binding—HTR1D—migraine	0.000203	0.00176	CbGpPWpGaD
Terazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—migraine	0.000202	0.00176	CbGpPWpGaD
Terazosin—Headache—Valproic Acid—migraine	0.000202	0.000867	CcSEcCtD
Terazosin—Paraesthesia—Topiramate—migraine	0.000202	0.000867	CcSEcCtD
Terazosin—ADRA1A—G alpha (q) signalling events—HTR2C—migraine	0.000201	0.00175	CbGpPWpGaD
Terazosin—Dyspnoea—Topiramate—migraine	0.0002	0.000861	CcSEcCtD
Terazosin—Somnolence—Topiramate—migraine	0.0002	0.000858	CcSEcCtD
Terazosin—Dyspepsia—Topiramate—migraine	0.000198	0.00085	CcSEcCtD
Terazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—migraine	0.000197	0.00171	CbGpPWpGaD
Terazosin—Hypersensitivity—Gabapentin—migraine	0.000197	0.000845	CcSEcCtD
Terazosin—Diarrhoea—Timolol—migraine	0.000196	0.000843	CcSEcCtD
Terazosin—ADRA1A—G alpha (q) signalling events—EDNRA—migraine	0.000196	0.0017	CbGpPWpGaD
Terazosin—Decreased appetite—Topiramate—migraine	0.000195	0.000839	CcSEcCtD
Terazosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.000194	0.00169	CbGpPWpGaD
Terazosin—Fatigue—Topiramate—migraine	0.000194	0.000832	CcSEcCtD
Terazosin—Constipation—Topiramate—migraine	0.000192	0.000825	CcSEcCtD
Terazosin—Pain—Topiramate—migraine	0.000192	0.000825	CcSEcCtD
Terazosin—Asthenia—Gabapentin—migraine	0.000192	0.000823	CcSEcCtD
Terazosin—Nausea—Valproic Acid—migraine	0.000191	0.000822	CcSEcCtD
Terazosin—ADRA1D—GPCR downstream signaling—CALCRL—migraine	0.00019	0.00165	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—RAMP1—migraine	0.00019	0.00165	CbGpPWpGaD
Terazosin—Dizziness—Timolol—migraine	0.00019	0.000815	CcSEcCtD
Terazosin—Pruritus—Gabapentin—migraine	0.000189	0.000812	CcSEcCtD
Terazosin—ADRA1B—GPCR ligand binding—HTR2B—migraine	0.000188	0.00164	CbGpPWpGaD
Terazosin—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.000188	0.00164	CbGpPWpGaD
Terazosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.000187	0.00163	CbGpPWpGaD
Terazosin—Feeling abnormal—Topiramate—migraine	0.000185	0.000795	CcSEcCtD
Terazosin—ADRA1D—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.000185	0.00161	CbGpPWpGaD
Terazosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.000184	0.0016	CbGpPWpGaD
Terazosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.000184	0.0016	CbGpPWpGaD
Terazosin—Gastrointestinal pain—Topiramate—migraine	0.000184	0.000789	CcSEcCtD
Terazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—migraine	0.000183	0.0016	CbGpPWpGaD
Terazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—migraine	0.000183	0.0016	CbGpPWpGaD
Terazosin—Diarrhoea—Gabapentin—migraine	0.000183	0.000785	CcSEcCtD
Terazosin—Vomiting—Timolol—migraine	0.000182	0.000783	CcSEcCtD
Terazosin—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.000181	0.00158	CbGpPWpGaD
Terazosin—Rash—Timolol—migraine	0.000181	0.000777	CcSEcCtD
Terazosin—Dermatitis—Timolol—migraine	0.000181	0.000776	CcSEcCtD
Terazosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.000181	0.00157	CbGpPWpGaD
Terazosin—ADRA1A—GPCR ligand binding—HTR1D—migraine	0.00018	0.00157	CbGpPWpGaD
Terazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—migraine	0.00018	0.00156	CbGpPWpGaD
Terazosin—Headache—Timolol—migraine	0.00018	0.000772	CcSEcCtD
Terazosin—Body temperature increased—Topiramate—migraine	0.000178	0.000763	CcSEcCtD
Terazosin—Abdominal pain—Topiramate—migraine	0.000178	0.000763	CcSEcCtD
Terazosin—Dizziness—Gabapentin—migraine	0.000177	0.000759	CcSEcCtD
Terazosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.000176	0.00153	CbGpPWpGaD
Terazosin—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.000175	0.00152	CbGpPWpGaD
Terazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—migraine	0.000175	0.00152	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—CALCRL—migraine	0.000172	0.0015	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—RAMP1—migraine	0.000172	0.0015	CbGpPWpGaD
Terazosin—ABCB1—Transmembrane transport of small molecules—TRPM8—migraine	0.00017	0.00148	CbGpPWpGaD
Terazosin—Nausea—Timolol—migraine	0.00017	0.000732	CcSEcCtD
Terazosin—ADRA1B—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.00017	0.00148	CbGpPWpGaD
Terazosin—Vomiting—Gabapentin—migraine	0.00017	0.000729	CcSEcCtD
Terazosin—Rash—Gabapentin—migraine	0.000168	0.000723	CcSEcCtD
Terazosin—Dermatitis—Gabapentin—migraine	0.000168	0.000723	CcSEcCtD
Terazosin—Headache—Gabapentin—migraine	0.000167	0.000719	CcSEcCtD
Terazosin—ADRA1A—GPCR ligand binding—HTR2B—migraine	0.000167	0.00146	CbGpPWpGaD
Terazosin—ADRA1D—G alpha (q) signalling events—HTR2A—migraine	0.000167	0.00146	CbGpPWpGaD
Terazosin—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.000167	0.00145	CbGpPWpGaD
Terazosin—Hypersensitivity—Topiramate—migraine	0.000166	0.000711	CcSEcCtD
Terazosin—Asthenia—Topiramate—migraine	0.000161	0.000693	CcSEcCtD
Terazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.000161	0.0014	CbGpPWpGaD
Terazosin—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.000161	0.0014	CbGpPWpGaD
Terazosin—Pruritus—Topiramate—migraine	0.000159	0.000683	CcSEcCtD
Terazosin—Nausea—Gabapentin—migraine	0.000159	0.000681	CcSEcCtD
Terazosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.000158	0.00138	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—RAMP1—migraine	0.000158	0.00137	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—CALCRL—migraine	0.000158	0.00137	CbGpPWpGaD
Terazosin—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.000155	0.00135	CbGpPWpGaD
Terazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.000155	0.00135	CbGpPWpGaD
Terazosin—Diarrhoea—Topiramate—migraine	0.000154	0.00066	CcSEcCtD
Terazosin—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.000153	0.00133	CbGpPWpGaD
Terazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.000153	0.00133	CbGpPWpGaD
Terazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.000153	0.00133	CbGpPWpGaD
Terazosin—ADRA1A—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.000151	0.00132	CbGpPWpGaD
Terazosin—ABCB1—head—migraine	0.000151	0.00663	CbGeAlD
Terazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.00015	0.0013	CbGpPWpGaD
Terazosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—migraine	0.00015	0.0013	CbGpPWpGaD
Terazosin—Dizziness—Topiramate—migraine	0.000149	0.000638	CcSEcCtD
Terazosin—ADRA1D—GPCR ligand binding—HTR1B—migraine	0.000148	0.00129	CbGpPWpGaD
Terazosin—ABCB1—HIF-1-alpha transcription factor network—FOS—migraine	0.000146	0.00127	CbGpPWpGaD
Terazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.000146	0.00127	CbGpPWpGaD
Terazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.000143	0.00125	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—CALCRL—migraine	0.000143	0.00125	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—RAMP1—migraine	0.000143	0.00125	CbGpPWpGaD
Terazosin—ABCB1—nervous system—migraine	0.000143	0.00628	CbGeAlD
Terazosin—Vomiting—Topiramate—migraine	0.000143	0.000614	CcSEcCtD
Terazosin—ADRA1D—GPCR ligand binding—HTR1A—migraine	0.000142	0.00124	CbGpPWpGaD
Terazosin—Rash—Topiramate—migraine	0.000142	0.000609	CcSEcCtD
Terazosin—Dermatitis—Topiramate—migraine	0.000142	0.000608	CcSEcCtD
Terazosin—Headache—Topiramate—migraine	0.000141	0.000605	CcSEcCtD
Terazosin—ADRA1D—GPCR ligand binding—NPS—migraine	0.00014	0.00122	CbGpPWpGaD
Terazosin—ADRA1D—GPCR ligand binding—TAC1—migraine	0.00014	0.00122	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—CALCRL—migraine	0.00014	0.00122	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—RAMP1—migraine	0.00014	0.00122	CbGpPWpGaD
Terazosin—ADRA1B—G alpha (q) signalling events—HTR2A—migraine	0.000139	0.00121	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—HTR1D—migraine	0.000138	0.0012	CbGpPWpGaD
Terazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.000138	0.0012	CbGpPWpGaD
Terazosin—ABCB1—central nervous system—migraine	0.000138	0.00605	CbGeAlD
Terazosin—ADRA1D—GPCR ligand binding—HTR2C—migraine	0.000138	0.0012	CbGpPWpGaD
Terazosin—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.000136	0.00118	CbGpPWpGaD
Terazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.000136	0.00118	CbGpPWpGaD
Terazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.000136	0.00118	CbGpPWpGaD
Terazosin—ABCB1—cerebellum—migraine	0.000135	0.00591	CbGeAlD
Terazosin—ADRA1D—GPCR ligand binding—EDNRA—migraine	0.000134	0.00116	CbGpPWpGaD
Terazosin—Nausea—Topiramate—migraine	0.000134	0.000573	CcSEcCtD
Terazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.000133	0.00116	CbGpPWpGaD
Terazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.000131	0.00114	CbGpPWpGaD
Terazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.00013	0.00113	CbGpPWpGaD
Terazosin—ADRA1D—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	0.000129	0.00113	CbGpPWpGaD
Terazosin—ABCB1—Transmembrane transport of small molecules—ATP1A3—migraine	0.000129	0.00112	CbGpPWpGaD
Terazosin—ABCB1—Transmembrane transport of small molecules—ATP1A2—migraine	0.000129	0.00112	CbGpPWpGaD
Terazosin—ADRA1D—GPCR ligand binding—CALCA—migraine	0.000129	0.00112	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—HTR2B—migraine	0.000128	0.00112	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—RAMP1—migraine	0.000127	0.00111	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—CALCRL—migraine	0.000127	0.00111	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—HTR1D—migraine	0.000125	0.00109	CbGpPWpGaD
Terazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—migraine	0.000124	0.00108	CbGpPWpGaD
Terazosin—ADRA1A—G alpha (q) signalling events—HTR2A—migraine	0.000123	0.00107	CbGpPWpGaD
Terazosin—ADRA1B—GPCR ligand binding—HTR1B—migraine	0.000123	0.00107	CbGpPWpGaD
Terazosin—ADRA1D—GPCR ligand binding—HTR7—migraine	0.00012	0.00105	CbGpPWpGaD
Terazosin—ADRA1B—GPCR ligand binding—HTR1A—migraine	0.000118	0.00103	CbGpPWpGaD
Terazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.000117	0.00101	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—HTR2B—migraine	0.000117	0.00101	CbGpPWpGaD
Terazosin—ADRA1B—GPCR ligand binding—TAC1—migraine	0.000116	0.00101	CbGpPWpGaD
Terazosin—ADRA1B—GPCR ligand binding—NPS—migraine	0.000116	0.00101	CbGpPWpGaD
Terazosin—KCNH2—SIDS Susceptibility Pathways—TNF—migraine	0.000116	0.00101	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—HTR1D—migraine	0.000115	0.000997	CbGpPWpGaD
Terazosin—ADRA1B—GPCR ligand binding—HTR2C—migraine	0.000114	0.000993	CbGpPWpGaD
Terazosin—ADRA1B—GPCR ligand binding—EDNRA—migraine	0.000111	0.000966	CbGpPWpGaD
Terazosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	0.000111	0.000964	CbGpPWpGaD
Terazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—migraine	0.00011	0.00096	CbGpPWpGaD
Terazosin—ABCB1—Transmembrane transport of small molecules—HTR3A—migraine	0.00011	0.000956	CbGpPWpGaD
Terazosin—ABCB1—brain—migraine	0.000109	0.0048	CbGeAlD
Terazosin—ADRA1A—GPCR ligand binding—HTR1B—migraine	0.000109	0.000949	CbGpPWpGaD
Terazosin—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	0.000107	0.000934	CbGpPWpGaD
Terazosin—ADRA1B—GPCR ligand binding—CALCA—migraine	0.000107	0.00093	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—HTR2B—migraine	0.000106	0.000926	CbGpPWpGaD
Terazosin—ADRA1A—GPCR ligand binding—HTR1A—migraine	0.000105	0.000913	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—HTR1D—migraine	0.000104	0.000905	CbGpPWpGaD
Terazosin—ADRA1A—GPCR ligand binding—TAC1—migraine	0.000103	0.0009	CbGpPWpGaD
Terazosin—ADRA1A—GPCR ligand binding—NPS—migraine	0.000103	0.0009	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—RAMP1—migraine	0.000102	0.000886	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CALCRL—migraine	0.000102	0.000886	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—HTR1D—migraine	0.000102	0.000885	CbGpPWpGaD
Terazosin—ADRA1A—GPCR ligand binding—HTR2C—migraine	0.000101	0.000882	CbGpPWpGaD
Terazosin—ADRA1B—GPCR ligand binding—HTR7—migraine	0.0001	0.00087	CbGpPWpGaD
Terazosin—ADRA1A—GPCR ligand binding—EDNRA—migraine	9.86e-05	0.000858	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—HTR2B—migraine	9.67e-05	0.000841	CbGpPWpGaD
Terazosin—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	9.53e-05	0.00083	CbGpPWpGaD
Terazosin—ADRA1A—GPCR ligand binding—CALCA—migraine	9.49e-05	0.000826	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—HTR2B—migraine	9.46e-05	0.000823	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—HTR1D—migraine	9.24e-05	0.000804	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—migraine	9.22e-05	0.000802	CbGpPWpGaD
Terazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	9.2e-05	0.0008	CbGpPWpGaD
Terazosin—ADRA1A—GPCR ligand binding—HTR7—migraine	8.88e-05	0.000773	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—HTR2B—migraine	8.59e-05	0.000747	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—RAMP1—migraine	8.46e-05	0.000736	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CALCRL—migraine	8.46e-05	0.000736	CbGpPWpGaD
Terazosin—ADRA1D—GPCR ligand binding—HTR2A—migraine	8.44e-05	0.000734	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—HTR1B—migraine	8.36e-05	0.000727	CbGpPWpGaD
Terazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	8.17e-05	0.000711	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—HTR1A—migraine	8.05e-05	0.0007	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—TAC1—migraine	7.93e-05	0.00069	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—NPS—migraine	7.93e-05	0.00069	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—HTR2C—migraine	7.77e-05	0.000676	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—HTR1B—migraine	7.59e-05	0.000661	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—EDNRA—migraine	7.56e-05	0.000658	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CALCRL—migraine	7.51e-05	0.000654	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—RAMP1—migraine	7.51e-05	0.000654	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—HTR1D—migraine	7.4e-05	0.000644	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—HTR1A—migraine	7.31e-05	0.000636	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—CALCA—migraine	7.28e-05	0.000633	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—TAC1—migraine	7.2e-05	0.000626	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—NPS—migraine	7.2e-05	0.000626	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—HTR2C—migraine	7.06e-05	0.000614	CbGpPWpGaD
Terazosin—ADRA1B—GPCR ligand binding—HTR2A—migraine	7e-05	0.000609	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—HTR1B—migraine	6.94e-05	0.000604	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—migraine	6.92e-05	0.000602	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—HTR2B—migraine	6.88e-05	0.000599	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—EDNRA—migraine	6.87e-05	0.000597	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—HTR7—migraine	6.81e-05	0.000592	CbGpPWpGaD
Terazosin—ABCB1—Allograft Rejection—TNF—migraine	6.79e-05	0.000591	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—HTR1A—migraine	6.68e-05	0.000581	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—CALCA—migraine	6.61e-05	0.000575	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—NPS—migraine	6.58e-05	0.000572	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—TAC1—migraine	6.58e-05	0.000572	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—HTR2C—migraine	6.45e-05	0.000561	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—HTR1B—migraine	6.3e-05	0.000548	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—EDNRA—migraine	6.28e-05	0.000546	CbGpPWpGaD
Terazosin—ADRA1A—GPCR ligand binding—HTR2A—migraine	6.22e-05	0.000541	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—HTR7—migraine	6.18e-05	0.000538	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—HTR1B—migraine	6.16e-05	0.000536	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—HTR1D—migraine	6.14e-05	0.000535	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—HTR1A—migraine	6.07e-05	0.000528	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—LRP1—migraine	6.06e-05	0.000527	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—CALCA—migraine	6.04e-05	0.000526	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—NPS—migraine	5.97e-05	0.00052	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—TAC1—migraine	5.97e-05	0.00052	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—HTR1A—migraine	5.93e-05	0.000516	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—HTR2C—migraine	5.86e-05	0.00051	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—TAC1—migraine	5.84e-05	0.000508	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—NPS—migraine	5.84e-05	0.000508	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—HTR2C—migraine	5.73e-05	0.000499	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—HTR2B—migraine	5.71e-05	0.000497	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—EDNRA—migraine	5.7e-05	0.000496	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—HTR7—migraine	5.65e-05	0.000492	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—HTR1B—migraine	5.6e-05	0.000487	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—EDNRA—migraine	5.57e-05	0.000485	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—CALCA—migraine	5.49e-05	0.000477	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—HTR1D—migraine	5.46e-05	0.000475	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—HTR1A—migraine	5.39e-05	0.000469	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—CALCA—migraine	5.37e-05	0.000467	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—TAC1—migraine	5.31e-05	0.000462	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—NPS—migraine	5.31e-05	0.000462	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—HTR2C—migraine	5.2e-05	0.000453	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—HTR7—migraine	5.13e-05	0.000446	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—HTR2B—migraine	5.07e-05	0.000441	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—EDNRA—migraine	5.06e-05	0.00044	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—LRP1—migraine	5.03e-05	0.000438	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—HTR7—migraine	5.02e-05	0.000437	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—CALCA—migraine	4.87e-05	0.000424	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—HTR2A—migraine	4.77e-05	0.000415	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—NOTCH4—migraine	4.65e-05	0.000404	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—HTR7—migraine	4.56e-05	0.000397	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—HTR1B—migraine	4.49e-05	0.00039	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—LRP1—migraine	4.47e-05	0.000389	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—CACNA1A—migraine	4.37e-05	0.000381	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—HTR2A—migraine	4.33e-05	0.000377	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—HTR1A—migraine	4.32e-05	0.000376	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—TAC1—migraine	4.25e-05	0.00037	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—PGR—migraine	4.25e-05	0.00037	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—NPS—migraine	4.25e-05	0.00037	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—HTR2C—migraine	4.17e-05	0.000363	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—EDNRA—migraine	4.06e-05	0.000353	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—HTR2A—migraine	3.96e-05	0.000344	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—NOTCH3—migraine	3.95e-05	0.000344	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CALCA—migraine	3.9e-05	0.00034	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—NOTCH4—migraine	3.86e-05	0.000336	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—HTR1B—migraine	3.72e-05	0.000324	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—HTR7—migraine	3.65e-05	0.000318	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—HTR2A—migraine	3.59e-05	0.000313	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—HTR1A—migraine	3.58e-05	0.000312	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PGR—migraine	3.53e-05	0.000307	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—TAC1—migraine	3.53e-05	0.000307	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—NPS—migraine	3.53e-05	0.000307	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—HTR2A—migraine	3.52e-05	0.000306	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—HTR2C—migraine	3.46e-05	0.000301	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—NOTCH4—migraine	3.43e-05	0.000298	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—EDNRA—migraine	3.37e-05	0.000293	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—migraine	3.35e-05	0.000292	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—HTR1B—migraine	3.31e-05	0.000288	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—NOTCH3—migraine	3.28e-05	0.000285	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CALCA—migraine	3.24e-05	0.000282	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—HTR2A—migraine	3.19e-05	0.000278	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—HTR1A—migraine	3.18e-05	0.000277	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—TGFBR2—migraine	3.15e-05	0.000274	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—NPS—migraine	3.13e-05	0.000273	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—TAC1—migraine	3.13e-05	0.000273	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PGR—migraine	3.13e-05	0.000273	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—HTR2C—migraine	3.07e-05	0.000267	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—HTR7—migraine	3.03e-05	0.000264	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—EDNRA—migraine	2.99e-05	0.00026	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—NOTCH3—migraine	2.91e-05	0.000254	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CALCA—migraine	2.88e-05	0.00025	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—HTR7—migraine	2.69e-05	0.000234	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—TGFBR2—migraine	2.61e-05	0.000227	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—HTR2A—migraine	2.56e-05	0.000223	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—TGFBR2—migraine	2.32e-05	0.000202	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—ESR1—migraine	2.27e-05	0.000198	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—HTR2A—migraine	2.12e-05	0.000185	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—HTR2A—migraine	1.89e-05	0.000164	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—ESR1—migraine	1.88e-05	0.000164	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—ESR1—migraine	1.67e-05	0.000146	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—MTHFR—migraine	1.45e-05	0.000126	CbGpPWpGaD
